调强放疗联合紫杉醇加奈达铂及重组改构人肿瘤坏死因子α治疗局部进展期食管癌的近期疗效临床观察
陈丽;汪步海;袁一枫;蒋亚齐;戴尔珣;郭隽;邢恩明
【期刊名称】《癌症进展》
【年(卷),期】2016(014)011
【摘要】Objective To explore the effectiveness and safety of concurrent intensity-modulated radiotherapy (IMRT) combined with paclitaxel plus nedaplatin (TP) and modified recombinant human tumor necrosis factor-α(rhTNF-α) in pa-tients with locally advanced esophageal carcinoma (EC). Method 40 patients with esophageal cancer were included in the study, and all were administered with IMRT+TP and rhTNF-α. Th e short-term efficacy and toxicities were evaluated, and then patients were stratified as cervical/upper-thoracic EC group and mid-/lower-thoracic EC group, for which the short-term efficacy and toxicities, as well as the occurrence of esophageal strictures were further compared. Result In the 40 patients, there were 20(50%) cases of CR, 16(40%) cases of PR, and the ORR was 90%(36/40). Leucopenia was the most common hematological toxicity seen in all patients, and non-hematological toxicities were mild. After treatment, the incidence of moderate-to-severe esophageal strictures were 63.63%(14/22) and 11.11%(2/18) in cervical/upper-thorac-ic and mid-
/lower-thoracic groups, respectively, with statistically significant difference observed (P<0.001). Conclusion The concurrent chemoradiotherapy of
IMRT combined with TP regimen and rhTNF-αis fairly effective in patients with locally advanced esophageal cancer, with tolerable toxicities; Besides, patients with cervical/upper-thoracic esophageal cancer are more likely to develop esophageal stricture, which is of clinical significance.%目的探讨调强放疗(IMRT)联合紫杉醇加奈达铂(TP)及注射用重组改构人肿瘤坏死因子
α(rhTNF-α)治疗食管癌的近期疗效及安全性,并评价食管癌部位与食管狭窄的相关性.方法对40例罹患不同部位食管癌的患者进行ⅠMRT+TP方案+rhTNF-α治疗.评价近期疗效及不良反应,另外,按食管癌发生部位将患者分为颈胸上段组和胸中下段组,进一步比较两组的近期疗效和不良反应以及食管狭窄情况.结果 40例患者中CR 20例(50%),PR 16例(40%),总有效率为90%(36/40).治疗相关血液学不良反应以白细胞减少为主,非血液学不良反应均较轻微.治疗后食管癌颈胸上段组和胸中下段组的中度及以上食管狭窄发生率分别为63.64%(14/22)和11.11%(2/18),差异有统计学意义(P<0.001).结论食管癌同步放化疗联合重组改构人肿瘤坏死因子α治疗食管癌疗效确切,不良反应均可耐受,但颈胸上段食管癌放疗后食管狭窄程度较重,应加以重视.
【总页数】4页(P1121-1123,1127)
【作者】陈丽;汪步海;袁一枫;蒋亚齐;戴尔珣;郭隽;邢恩明
【作者单位】江苏省苏北人民医院肿瘤科,江苏扬州2250010;江苏省苏北人民医院肿瘤科,江苏扬州2250010;江苏省苏北人民医院肿瘤科,江苏扬州2250010;江苏省苏北人民医院肿瘤科,江苏扬州2250010;江苏省苏北人民医院肿瘤科,江苏扬州2250010;江苏省苏北人民医院肿瘤科,江苏扬州2250010;江苏省苏北人民医院肿瘤科,江苏扬州2250010
【正文语种】中文
【中图分类】R735.1
【相关文献】
1.洛铂联合调强放疗治疗局部进展期食管癌的近期疗效观察 [J], 周广禹;李明君
2.紫杉醇脂质体加奈达铂联合放疗治疗老年食管癌的临床观察 [J], 朱琪伟;万志龙;郭金涛
3.紫杉醇加奈达铂方案联合脾多肽注射液治疗晚期食管癌临床观察 [J], 张素珍;杨牡丹;刘俊
4.脂质体紫杉醇联合奈达铂与紫杉醇联合奈达铂一线治疗晚期非小细胞肺癌的临床观察 [J], 李秋萍;王卫
5.调强放疗联合紫杉醇及奈达铂化疗治疗食管癌的临床观察 [J], 吴志军;肖泽民;郑江;田伟
因版权原因，仅展示原文概要，查看原文内容请购买。